| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.
|
Nature
|
2011
|
13.25
|
|
2
|
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
|
Ann Intern Med
|
2014
|
12.79
|
|
3
|
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.
|
Lancet
|
2012
|
12.10
|
|
4
|
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
|
Lancet
|
2009
|
11.81
|
|
5
|
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.
|
Nat Genet
|
2012
|
11.09
|
|
6
|
Major lipids, apolipoproteins, and risk of vascular disease.
|
JAMA
|
2009
|
10.58
|
|
7
|
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.
|
Lancet
|
2011
|
9.07
|
|
8
|
Large-scale association analysis identifies new risk loci for coronary artery disease.
|
Nat Genet
|
2012
|
7.59
|
|
9
|
Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys.
|
Lancet
|
2002
|
7.43
|
|
10
|
Prevalence of serious mental disorder in 7000 refugees resettled in western countries: a systematic review.
|
Lancet
|
2005
|
6.88
|
|
11
|
C-reactive protein, fibrinogen, and cardiovascular disease prediction.
|
N Engl J Med
|
2012
|
6.39
|
|
12
|
Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.
|
Circulation
|
2006
|
6.17
|
|
13
|
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
|
JAMA
|
2009
|
5.63
|
|
14
|
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
|
JAMA
|
2005
|
5.60
|
|
15
|
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
|
Lancet
|
2010
|
5.31
|
|
16
|
Inactivating mutations in NPC1L1 and protection from coronary heart disease.
|
N Engl J Med
|
2014
|
4.94
|
|
17
|
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
|
Lancet
|
2012
|
4.63
|
|
18
|
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.
|
Lancet
|
2016
|
4.49
|
|
19
|
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
|
Lancet
|
2010
|
4.46
|
|
20
|
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.
|
JAMA
|
2008
|
4.21
|
|
21
|
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.
|
Nat Genet
|
2014
|
4.13
|
|
22
|
Association of apolipoprotein E genotypes with lipid levels and coronary risk.
|
JAMA
|
2007
|
4.03
|
|
23
|
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies.
|
Int J Epidemiol
|
2010
|
3.97
|
|
24
|
Lipid-related markers and cardiovascular disease prediction.
|
JAMA
|
2012
|
3.91
|
|
25
|
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
|
N Engl J Med
|
2016
|
3.88
|
|
26
|
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.
|
BMJ
|
2011
|
3.65
|
|
27
|
Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci.
|
Nat Genet
|
2011
|
3.46
|
|
28
|
A road map for efficient and reliable human genome epidemiology.
|
Nat Genet
|
2006
|
3.21
|
|
29
|
Genetic associations with valvular calcification and aortic stenosis.
|
N Engl J Med
|
2013
|
3.02
|
|
30
|
Common variants associated with plasma triglycerides and risk for coronary artery disease.
|
Nat Genet
|
2013
|
2.92
|
|
31
|
Adiponectin and coronary heart disease: a prospective study and meta-analysis.
|
Circulation
|
2006
|
2.89
|
|
32
|
Seventy-five genetic loci influencing the human red blood cell.
|
Nature
|
2012
|
2.77
|
|
33
|
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.
|
Lancet
|
2006
|
2.72
|
|
34
|
Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
|
Int J Epidemiol
|
2006
|
2.68
|
|
35
|
Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies.
|
Lancet
|
2004
|
2.55
|
|
36
|
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
|
Am J Hum Genet
|
2012
|
2.53
|
|
37
|
Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study.
|
Eur Heart J
|
2011
|
2.42
|
|
38
|
Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E epsilon2/epsilon3/epsilon4 genotype.
|
Lancet
|
2003
|
2.40
|
|
39
|
B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies.
|
Circulation
|
2009
|
2.37
|
|
40
|
Genetically determined height and coronary artery disease.
|
N Engl J Med
|
2015
|
2.24
|
|
41
|
Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies.
|
Int J Epidemiol
|
2006
|
2.22
|
|
42
|
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.
|
Diabetes
|
2011
|
2.21
|
|
43
|
Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants.
|
J Am Coll Cardiol
|
2010
|
2.20
|
|
44
|
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.
|
Am J Hum Genet
|
2010
|
2.15
|
|
45
|
Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals.
|
Eur Heart J
|
2004
|
2.06
|
|
46
|
Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.
|
PLoS Med
|
2010
|
2.02
|
|
47
|
Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.
|
Arch Intern Med
|
2008
|
2.01
|
|
48
|
Suicides in male prisoners in England and Wales, 1978-2003.
|
Lancet
|
2005
|
1.82
|
|
49
|
Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.
|
Circulation
|
2013
|
1.77
|
|
50
|
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.
|
Am J Epidemiol
|
2008
|
1.71
|
|
51
|
The emergence of networks in human genome epidemiology: challenges and opportunities.
|
Epidemiology
|
2007
|
1.61
|
|
52
|
Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk.
|
Int J Epidemiol
|
2004
|
1.59
|
|
53
|
Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies.
|
Eur Heart J
|
2007
|
1.55
|
|
54
|
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.
|
Eur Heart J
|
2013
|
1.53
|
|
55
|
Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
|
PLoS Med
|
2005
|
1.50
|
|
56
|
Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study.
|
BMJ
|
2010
|
1.50
|
|
57
|
Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases.
|
PLoS Genet
|
2013
|
1.47
|
|
58
|
A network of investigator networks in human genome epidemiology.
|
Am J Epidemiol
|
2005
|
1.43
|
|
59
|
Leptin and coronary heart disease: prospective study and systematic review.
|
J Am Coll Cardiol
|
2009
|
1.39
|
|
60
|
Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India.
|
Diabetes
|
2013
|
1.36
|
|
61
|
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies.
|
PLoS Med
|
2006
|
1.35
|
|
62
|
The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia.
|
Eur J Epidemiol
|
2009
|
1.31
|
|
63
|
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
|
PLoS Med
|
2012
|
1.27
|
|
64
|
Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.
|
Blood
|
2012
|
1.26
|
|
65
|
Association of the 9p21.3 locus with risk of first-ever myocardial infarction in Pakistanis: case-control study in South Asia and updated meta-analysis of Europeans.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.23
|
|
66
|
Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.
|
PLoS Med
|
2007
|
1.15
|
|
67
|
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.
|
Circ Res
|
2017
|
1.06
|
|
68
|
Association between walking speed and age in healthy, free-living individuals using mobile accelerometry--a cross-sectional study.
|
PLoS One
|
2011
|
1.06
|
|
69
|
C-reactive protein and coronary disease: is there a causal link?
|
Circulation
|
2009
|
1.03
|
|
70
|
GUESS-ing polygenic associations with multiple phenotypes using a GPU-based evolutionary stochastic search algorithm.
|
PLoS Genet
|
2013
|
1.03
|
|
71
|
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association.
|
Am J Epidemiol
|
2007
|
1.01
|
|
72
|
The association between psychiatric diagnosis and violent re-offending in adult offenders in the community.
|
BMC Psychiatry
|
2008
|
0.96
|
|
73
|
Genetic determinants of major blood lipids in Pakistanis compared with Europeans.
|
Circ Cardiovasc Genet
|
2010
|
0.95
|
|
74
|
Are myocardial infarction--associated single-nucleotide polymorphisms associated with ischemic stroke?
|
Stroke
|
2012
|
0.91
|
|
75
|
Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women.
|
Thromb Res
|
2011
|
0.90
|
|
76
|
Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort).
|
J Am Coll Cardiol
|
2013
|
0.88
|
|
77
|
NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study.
|
Atherosclerosis
|
2009
|
0.85
|
|
78
|
Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies.
|
BMJ
|
2002
|
0.84
|
|
79
|
Hemostatic and rheological variables and risk of cardiovascular disease.
|
Semin Vasc Med
|
2002
|
0.79
|
|
80
|
Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis.
|
Eur Heart J
|
2003
|
0.79
|
|
81
|
Prevalence of epilepsy in prisoners: systematic review.
|
BMJ
|
2002
|
0.79
|
|
82
|
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.
|
Lancet Diabetes Endocrinol
|
2016
|
0.78
|
|
83
|
Association of dietary, circulating, and supplement fatty acids with coronary risk. In response.
|
Ann Intern Med
|
2014
|
0.78
|
|
84
|
The Bangladesh Risk of Acute Vascular Events (BRAVE) Study: objectives and design.
|
Eur J Epidemiol
|
2015
|
0.77
|
|
85
|
Risk factors: Lipoprotein(a) and coronary disease-moving closer to causality.
|
Nat Rev Cardiol
|
2009
|
0.77
|
|
86
|
C-reactive protein, fibrinogen, and cardiovascular risk.
|
N Engl J Med
|
2013
|
0.76
|
|
87
|
BRCA2 variants and cardiovascular disease in a multi-ethnic study.
|
BMC Med Genet
|
2012
|
0.75
|
|
88
|
Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease.
|
Int J Mol Epidemiol Genet
|
2011
|
0.75
|
|
89
|
Coronary heart disease.
|
IARC Sci Publ
|
2011
|
0.75
|
|
90
|
REPEATED MEASUREMENTS OF BLOOD PRESSURE AND CHOLESTEROL IMPROVES CARDIOVASCULAR DISEASE RISK PREDICTION: AN INDIVIDUAL-PARTICIPANT-DATA META-ANALYSIS.
|
Am J Epidemiol
|
2017
|
0.75
|
|
91
|
New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals.
|
Circ Cardiovasc Genet
|
2017
|
0.75
|
|
92
|
The need for risk factor assessment in atherothrombotic vascular disease.
|
Semin Vasc Med
|
2002
|
0.75
|